The Canadian health-tech sector faces regulatory challenges amidst rapid innovations in artificial intelligence (AI), digital health, biotechnology, and medical devices. This paper explores the regulatory landscape based on stakeholder interviews and proposes a framework that balances patient safety with innovation. Key elements include open data access, long-term government funding, monitoring of anti-competitive behavior, and alignment with international standards.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3233/SHTI250032 | DOI Listing |
Stud Health Technol Inform
February 2025
The Canadian health-tech sector faces regulatory challenges amidst rapid innovations in artificial intelligence (AI), digital health, biotechnology, and medical devices. This paper explores the regulatory landscape based on stakeholder interviews and proposes a framework that balances patient safety with innovation. Key elements include open data access, long-term government funding, monitoring of anti-competitive behavior, and alignment with international standards.
View Article and Find Full Text PDFJ Med Internet Res
December 2024
Centre for Digital Health Interventions, School of Medicine, University of St. Gallen, St. Gallen, Switzerland.
Digit Health
November 2023
Department of Management Studies, Indian Institute of Technology Delhi, New Delhi, India.
Health technology startups are experiencing a significant surge in growth, particularly since the COVID-19 pandemic, as they address gaps in the sector. However, despite their increasing prevalence, there is still relatively limited knowledge about this sector's evolution. This opinion article explores emerging trends in health startups, including their market size, growth, significant challenges, and guidelines for key stakeholders from a global healthcare service industry perspective.
View Article and Find Full Text PDFJ Med Internet Res
June 2022
Division of Gastroenterology & Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Background: The digital health sector has experienced rapid growth over the past decade. However, health care technology stakeholders lack a comprehensive understanding of clinical robustness and claims across the industry.
Objective: This analysis aimed to examine the clinical robustness and public claims made by digital health companies.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!